Rankings
▼
Calendar
IMNM Q4 2019 Earnings — Immunome, Inc. Revenue & Financial Results | Market Cap Arena
IMNM
Immunome, Inc.
$2B
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-0.51
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$3,000
Balance Sheet
Total Assets
$5M
Total Liabilities
$41M
Stockholders' Equity
-$36M
Cash & Equivalents
$3M
← FY 2019
All Quarters
Q1 2020 →
